Chiral drugs: comparison of the pharmacokinetics of [ 11 C] d-threo and l-threo -methylphenidate in the human and baboon brain
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Methylphenidate (Ritalin) is the most commonly prescribed psychoactive medication for children in the US where it is used for the treatment of attention deficit hyperactivity disorder. Methylphenidate is marketed as a racemic mixture of the d-threo and l-threo enantiomers. It is believed that the d enantiomer is responsible for the therapeutic effect of methylphenidate. In this study we labeled the individual enantiomers with carbon-11 and compared their binding and pharmacokinetics in the human and baboon brain. Microdialysis studies in the rat were performed to compare their potency in elevating striatal dopamine concentration. Positron emission tomographic (PET) studies with [11C]d-threo-methylphenidate ([11C]d-threo-MP) demonstrated highest regional uptake in basal ganglia. In contrast, [11C]l-threo-methylphenidate ([11C]l-threo-MP) displayed similar uptakes in all brain regions. The ratios of distribution volumes at the steady-state for the basal ganglia to cerebellum (DVBG/DVCB) ranged from 2.2 to 3.3 for [11C]d-threo-MP in baboon and human, and only 1.1 for [11C]l-threo-MP. Pretreatment with unlabeled methylphenidate (0.5 mg/kg) or GBR12909 (1.5 mg/kg) markedly reduced the striatal but not the cerebellar uptake of [11C]d-threo-MP, whereas there was no effect on DVBG/DVCB for [11C]l-threo-MP. In the rat, d-threo-MP increased extracellular dopamine concentration by 650% whereas l-threo-MP did not affect dopamine levels. These results indicate that pharmacological specificity of MP resides entirely in the d-threo isomer and directly show that binding of the l-isomer in human brain is mostly nonspecific.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180 · cited 1×
“However, it has been shown that d-threo-MP is more potent in the induction of locomotor activity and has a higher affinity for the dopamine transporter than l-threo-MP (Barkely 1977; Schweri et al. 1985; Patrick et al. 1987; Ritz et al. 1987; Pan et al. 1994).”
BackgroundLogan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., Hitzemann, R., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,479
Self-citationHyperactive Boys Almost Grown Up: I. Psychiatric Status
Gittelman, R. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790330017002 · Cited by 977
A REVIEW OF STIMULANT DRUG RESEARCH WITH HYPERACTIVE CHILDREN
Barkley, R. A. (1977) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1977.tb00425.x · Cited by 541 · cited 1×
“Attention deficit hyperactivity disorder (ADHD), which is estimated to affect more than 2 million children (or 3‐5%), has become America’s no. 1 childhood psychiatric disorder ( Barkley 1977 ).”
BackgroundImaging endogenous dopamine competition with [11C]raclopride in the human brain
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Schlyer, D., Hitzemann, R., Lieberman, J., Angrist, B., Pappas, N., MacGregor, R., et al. (1994) · Synapse · doi:10.1002/syn.890160402 · Cited by 379
Self-citationZetterström, T., Sharp, T., Collin, A. K., & Ungerstedt, U. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90110-0 · Cited by 378 · cited 1×
“The mechanism(s) which make methylphenidate work for ADHD patients is still unclear, though it has been suggested that the stimulant appears to increase the level of extracellular dopamine in the frontal lobe of the brain ( Zetterstrom et al. 1988; Butcher et al. 1991; Volkow et al. 1994), where it regulates attention…”
BackgroundThe dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action
Andersen, P. H. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90363-4 · Cited by 346
FERRIS, R. M., TANG, F. L. M., & MAXWELL, R. A. (1972) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29222-9 · Cited by 301
PET evaluation of the dopamine system of the human brain.
Volkow, N. D., Fowler, J., Sj, G., Logan, J., Wang, G., Ding, Y., & Dewey, S. L. (1996) · PubMed · Cited by 299
Self-citationDopamine transporters decrease with age.
Volkow, N. D., Ding, Y., Fowler, J. S., Wang, G., Logan, J., Gatley, S. J., Hitzemann, R., Smith, G., Fields, S. D., & Gur, R. C. (1996) · PubMed · Cited by 262
Self-citation
Cited by
Items 101–158 of 158
Kowalik, S. C., Minami, H., & Silva, R. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.18.2547 · Cited by 10
“D-MPH was also found to increase cerebral extracellular dopamine (DA) by 650% in rats, whereas the L form did not significantly increase this neurotransmitter [25].”
BackgroundInfluentialCombs, C. C., Hankins, E. L., Copeland, C. L., Brown, S. D., & Pond, B. B. (2013) · Biomedical Chromatography · doi:10.1002/bmc.2975 · Cited by 8
Spencer, T. J., Biederman, J., Martin, J. M., Martin, J. M., Moorehead, T. M., Mirto, T., Clarke, A., Batchelder, H., & Faraone, S. V. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.01.2529 · Cited by 9
“Plasma concentration of d-MPH was measured because this enantiomer has been shown to be the active moiety.(12) Drug Rating Questionnaires (DRQs) were completed each hour for up to 16 hours.”
MethodAttention-Deficit/Hyperactivity Disorder: Diagnosis and Treatment
REIFF, M. I., & Stein, M. T. (2004) · Advances in Pediatrics · doi:10.1016/s0065-3101(23)00043-9 · Cited by 8
Teuscher, N. S., Sikes, C. R., McMahen, R., & Engelking, D. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000944 · Cited by 8
“Copyright © 2018 Wolters Kluwer most medications provide MPH as a racemic mixture of D- and L-MPH, the D-threo-MPH (D-MPH) enantiomer is the most pharmacologically active.(7) Metabolism mainly occurs in the liver, where de-esterification by the carboxylesterase CES1A1 creates the main inactive metabolite, ritalinic ac…”
BackgroundGorka, A. X., Lago, T. R., Balderston, N. L., Torrisi, S., Fuchs, B. A., Grillon, C., & Ernst, M. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05505-z · Cited by 10
Molecular Chiral Response Enhanced by Crosstalking Quasi-Bound States in the Continuum
Shakirova, D., Valero, A. C., Riabov, D., Altug, H., Bogdanov, A., & Weiss, T. (2025) · ACS Photonics · doi:10.1021/acsphotonics.5c01225 · Cited by 7
Sayalı, C., van den Bosch, R., Määttä, J. I., Hofmans, L., Papadopetraki, D., Booij, J., Verkes, R., Baas, M., & Cools, R. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01615-2 · Cited by 7
“MPH blocks both the noradrenaline and the dopamine transporter [95, 96], leading to increases in noradrenaline and dopamine in the PFC [28] and striatum [97].”
BackgroundLi, Q. Q., Duan, J., Wu, L. J., Huang, Y., Tang, G., & Min, S. G. (2012) · Chinese Chemical Letters · doi:10.1016/j.cclet.2012.07.003 · Cited by 7
Central Nervous System Stimulants
Vardanyan, R., & Hruby, V. J. (2006) · Elsevier eBooks · doi:10.1016/b978-044452166-8/50008-x · Cited by 7
Morgan, A. J., Pandya, B. A., Masse, C. E., & Harbeson, S. L. (2012) · Wiley eBooks · doi:10.1002/9781118274408.ch10 · Cited by 7
Positron emission tomography studies in adult patients with attention-deficit/hyperactivity disorder
Yamamoto, M., & Inada, T. (2022) · Japanese Journal of Radiology · doi:10.1007/s11604-022-01368-w · Cited by 6
Li, Q., Huang, Y., Duan, J., Wu, L., Tang, G., Zhu, Y., & Min, S. (2012) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2012.09.065 · Cited by 6
Progress in PET Imaging of the Norepinephrine Transporter System
Ding, Y. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_19 · Cited by 6
Self-citationShort- and Long-Term Stability of Methylphenidate and Its Metabolites in Blood
Smith, C. R., & Swortwood, M. J. (2021) · Journal of Analytical Toxicology · doi:10.1093/jat/bkab063 · Cited by 6
Theoretical study on gas-phase conformations and vibrational assignment of methylphenidate
Bayarı, S. H., Seymen, B., Özışık, H., & Sağlam, S. (2008) · Journal of Molecular Structure THEOCHEM · doi:10.1016/j.theochem.2008.09.014 · Cited by 5
Peñuelas, I. (2001) · Revista Española de Medicina Nuclear · doi:10.1016/s0212-6982(01)71997-0 · Cited by 6
Smith, C. R., & Swortwood, M. J. (2022) · Forensic Chemistry · doi:10.1016/j.forc.2022.100400 · Cited by 4
Reyes-Vasquez, C., Jones, Z., Tang, B., & Dafny, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316628 · Cited by 4
“Studies in the literature report differences in the brain concentrations of DA, NE, and 5HT transporters [45,46].”
BackgroundProgress in PET Imaging of the Norepinephrine Transporter System
Ding, Y. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_20 · Cited by 7
Self-citationDopamine and Glutamate in Attention Deficit Hyperactivity Disorder
Swanson, J. M., Volkow, N. D., Newcorn, J. H., Casey, B. J., Moyzis, R. K., Grandy, D. K., & Posner, M. I. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-852-6_13 · Cited by 5
Self-citationPreparation and structural analysis of (±)-threo-ritalinic acid
Wyss, S., Werner, I. A., Schweizer, W. B., Ametamey, S. M., & Sephton, S. M. (2013) · Acta Crystallographica Section C Crystal Structure Communications · doi:10.1107/s010827011302595x · Cited by 2
“The therapeutic effects of enhanced attention, organization, planning, motivation and motor control arise from blocking of the re-uptake of dopamine into the presynaptic neurons of the basal ganglia and frontal cortex (Ding et al., 1997; Kimko et al., 1999; Scahill et al., 2004).”
BackgroundPharmacotherapy of Attention-Deficit/Hyperactivity Disorder across the Life Span
Prince, J. B., Spencer, T. J., Wilens, T. E., & Biederman, J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04743-2.50051-2 · Cited by 3
Świderski, N., Rodek, P., & Kucia, K. A. (2025) · Brain Sciences · doi:10.3390/brainsci15080850 · Cited by 2
“Methylphenidate (MPH) is a derivative of 2-piperidineacetic acid and exists in four isomers, thus having two stereogenic centers [42].”
Lyseng-Williamson, K. A. (2017) · Drugs & Therapy Perspectives · doi:10.1007/s40267-017-0462-2 · Cited by 3
The rate of dasotraline brain entry is slow following intravenous administration
Lew, R., Constantinescu, C. C., Holden, D., Carson, R. E., Carroll, V. M., Galluppi, G. R., Koblan, K. S., & Hopkins, S. C. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05623-8 · Cited by 2
Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung ADHS) im Erwachsenenalter
Alm, B., & Sobanski, E. (2008) · Springer eBooks · doi:10.1007/978-3-540-33129-2_64 · Cited by 3
Dafny, N., Claussen, C. M., Frazier, E., & Liu, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115938 · Cited by 1
“These studies report differences in the brain concentrations of DA, NE, and 5HT transporters following MPD exposure [21,39].”
BackgroundCentral Nervous System Stimulants
Vardanyan, R., & Hruby, V. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-411492-0.00008-0 · Cited by 2
Yuan, A., Claussen, C. M., Jones, Z., Tang, B., & Dafny, N. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02665-y · Cited by 1
“These studies report differences in the brain concentrations of DA, NE, and 5HT transporters (Ding et al. 1997; Volkow et al. 1995).”
BackgroundFunctional Brain Imaging and Large Animal Research
Peremans, K. Y., Audenaert, K., Verschooten, F., Otte, A., Slegers, G., & Dierckx, R. A. J. O. (2004) · Springer eBooks · doi:10.1007/978-3-642-18773-5_9 · Cited by 1
Somkuwar, S. S. (2013) · UKnowledge (University of Kentucky)
Telang, F., & Vblkow, N. D. (2000) · Elsevier eBooks · doi:10.1016/b978-012481460-8/50025-1
Neuropharmacology of Attention‐Deficit/Hyperactivity Disorder
Glaser, P. E. A., Castellanos, F. X., & Margulies, D. S. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn056
PET IMAGING OF THE PHARMACOKINETICS OF SMALL MOLECULAR‐WEIGHT DRUGS
Moerlein, S. M., & Tu, Z. (2013) · Wiley eBooks · doi:10.1002/9781118356845.ch7
Альтшулер, Р. А. (2005) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-005-0110-3
Dexmethylphenidate Extended Release in Attention-Deficit Hyperactivity Disorder
Masi, G., & Zuddas, A. (2006) · Drugs · doi:10.2165/00003495-200666050-00008
Dreyer, J. (2015) · Boloka Institutional Repository (North-west University)
Carboxylic Ester Containing Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs)
O’Neill, D. J. (2016) · Wiley-VCH eBooks · doi:10.1002/9783527693931.ch2
Kaminski, M., & Sjøgren, P. (2008) · Via Medica Journals
TRATAMIENTO FARMACOLÓGICO DEL TDAH Y LAS COMORBILIDADES
Prince, J. B., & Wilens, T. E. (2010) · Elsevier eBooks · doi:10.1016/b978-84-458-2021-6.00019-1
Minireview of Stereoselective Brain Imaging
Smith, D. F., & Jakobsen, S. (2014) · Archives of Current Research International · doi:10.9734/acri/2014/14787
Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung im Erwachsenenalter
Sobanski, E., Alm, B., & Thome, J. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_85
Unger, K. (2019) · Lu Zone Ul (Laurentian University)
Posner, J. E., Greenhill, L. L., & Nelson, J. C. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch108
Novel pharmacokinetic model to estimate dopamine dynamics in humans using PETPreprint
Tomasi, D. G., Manza, P., Logan, J., Kojori, E. S., Yonga, M.-V., Kroll, D. S., Feldman, D., McPherson, K. L., Biesecker, C. L., Dennis, E., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1411479/v1
Self-citationAufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Erwachsenenalter
Alm, B., & Sobanski, E. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_73 · Cited by 1
von Bruchhausen, F., Ebel, S., Hackenthal, E., Holzgrabe, U., Albinus, M., Amschler, G., Angerer, E. V., Arras‐Reiter, C., Bauer, A., Bauer, P., et al. (1999) · Springer eBooks · doi:10.1007/978-3-642-58388-9_2
Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung im Erwachsenenalter
Sobanski, E., Alm, B., & Thome, J. (2015) · Springer eBooks · doi:10.1007/978-3-642-45028-0_85-1 · Cited by 2
Taoka, T. (2025) · Medical radiology · doi:10.1007/174_2024_544
Central nervous system stimulants
Vardanyan, R., & Vardanyan, G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33869-4.00010-7
Staniszewska, M., Hübner, R., Locatelli, C., Howard, D., Forni, M., Man, F., Schoultz, B. W., Nuruddin, S., Hagen, I. S. N.-S., Mosessian, S., et al. (2026) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-026-00432-4
Świderski, N., & Bielecka, A. (2026) · Annales Academiae Medicae Silesiensis · doi:10.18794/aams/211947
“One pair of erythoisomers and one of threoisomers can be distinguished, of which d-threo-methylphenidate shows the most expected clinical properties [39].”
Dafny, N., Reyes-Vasquez, C., & Claussen, C. M. (2026) · Journal of Experimental Neurology · doi:10.33696/neurol.7.124
BindingDB (2011) · UC San Diego · doi:10.7270/q24f1qzz
Volkow (1999) · doi:10.1002/(sici)1098-2396(199901)31:1<59::aid-syn8>3.0.co;2-y
Self-citation
Metadata
- Authors
- Ding, Y.-S., Fowler, J. S., Volkow, N. D., Dewey, S. L., Wang, G.-J., Logan, J., Gatley, S. J., & Pappas, N.
- Affiliations
- Brookhaven National Laboratory (US)
- Venue
- Psychopharmacology
- Published
- 1997-05-15
- Volume
- 131
- Issue
- 1
- Pages
- 71-78
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1990494131
- Cited by
- 157
- References
- 31
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 5 · 2016: 3 · 2015: 4 · 2014: 7 · 2013: 4 · 2012: 11
- FWCI
- 3.74
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Licence
- public-domain
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, public-domain)
- Funders
- National Institutes of Health (2r01ns015380-27, 5p01ns015638-15)
- National Institute on Drug Abuse (DA-06278, R01DA006278)
- National Institute of Neurological Disorders and Stroke (NS15638, NS 15380)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- methylphenidate, enantiomers, chiral drugs, pharmacokinetics, brain distribution, striatal dopamine, basal ganglia, cerebellum, GBR 12909, attention deficit hyperactivity disorder, PET radiotracer, microdialysis, baboon brain, human brain
- MeSH terms
- Aged, Animals, Brain, Female, Humans, Male, Methylphenidate, Middle Aged, Papio, Radioligand Assay, Stereoisomerism, Tomography, Emission-Computed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.